1. Home
  2. RFL vs NTWK Comparison

RFL vs NTWK Comparison

Compare RFL & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • NTWK
  • Stock Information
  • Founded
  • RFL 2017
  • NTWK 1997
  • Country
  • RFL United States
  • NTWK United States
  • Employees
  • RFL N/A
  • NTWK N/A
  • Industry
  • RFL Real Estate
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • RFL Finance
  • NTWK Technology
  • Exchange
  • RFL Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • RFL 54.4M
  • NTWK 56.1M
  • IPO Year
  • RFL N/A
  • NTWK 1998
  • Fundamental
  • Price
  • RFL $1.34
  • NTWK $4.50
  • Analyst Decision
  • RFL
  • NTWK
  • Analyst Count
  • RFL 0
  • NTWK 0
  • Target Price
  • RFL N/A
  • NTWK N/A
  • AVG Volume (30 Days)
  • RFL 77.7K
  • NTWK 93.1K
  • Earning Date
  • RFL 12-10-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • RFL N/A
  • NTWK N/A
  • EPS Growth
  • RFL N/A
  • NTWK 316.67
  • EPS
  • RFL N/A
  • NTWK 0.25
  • Revenue
  • RFL $732,000.00
  • NTWK $66,088,229.00
  • Revenue This Year
  • RFL N/A
  • NTWK N/A
  • Revenue Next Year
  • RFL N/A
  • NTWK N/A
  • P/E Ratio
  • RFL N/A
  • NTWK $17.64
  • Revenue Growth
  • RFL 35.56
  • NTWK 7.65
  • 52 Week Low
  • RFL $1.28
  • NTWK $2.14
  • 52 Week High
  • RFL $3.19
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • RFL 45.24
  • NTWK 49.08
  • Support Level
  • RFL $1.32
  • NTWK $4.30
  • Resistance Level
  • RFL $1.44
  • NTWK $4.90
  • Average True Range (ATR)
  • RFL 0.07
  • NTWK 0.19
  • MACD
  • RFL 0.01
  • NTWK -0.03
  • Stochastic Oscillator
  • RFL 28.57
  • NTWK 33.33

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: